Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$24.0 million.

  • Molecular Partners Ag's Net Cash Flow fell 90674.08% to -$24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 10495.13%. This contributed to the annual value of -$4.9 million for FY2024, which is 10425.97% down from last year.
  • Per Molecular Partners Ag's latest filing, its Net Cash Flow stood at -$24.0 million for Q3 2025, which was down 90674.08% from $23.2 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Net Cash Flow ranged from a high of $115.5 million in Q4 2023 and a low of -$67.8 million during Q4 2021
  • In the last 5 years, Molecular Partners Ag's Net Cash Flow had a median value of $300.17 in 2024 and averaged $3.1 million.
  • The largest annual percentage gain for Molecular Partners Ag's Net Cash Flow in the last 5 years was 641449.33% (2025), contrasted with its biggest fall of 90674.08% (2025).
  • Over the past 5 years, Molecular Partners Ag's Net Cash Flow (Quarter) stood at -$67.8 million in 2021, then skyrocketed by 124.3% to $16.5 million in 2022, then skyrocketed by 600.92% to $115.5 million in 2023, then plummeted by 104.28% to -$4.9 million in 2024, then plummeted by 385.62% to -$24.0 million in 2025.
  • Its last three reported values are -$24.0 million in Q3 2025, $23.2 million for Q2 2025, and $19554.5 during Q1 2025.